Skip to main content
Equibles
ALGN logo

ALGN · Align Technology Inc

Track ALGN — free

Use ALGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$146.88 -0.73 (-0.49%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$10.48B
Shares
71.04M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$147.61 Open$149.52 Day$146.20–150.78 52W close$124.88–197.51 Avg vol 30d843K Short int3.9M · 5.4% float · 4.4d Short vol74% Last earningsJul 29, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Oct 28, 2026 Est · unconfirmed · in 5 wks
Latest filing: 10-Q
filed Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$4.14B
Trailing 12 months
Net income (TTM)
$413.58M
Trailing 12 months
Revenue growth YoY
+4.3%
Year over year
Operating margin
13.2%
Trailing 12 months
P / E (TTM)
25.7
Trailing earnings · reciprocal yield 3.9%
FCF yield
6.1%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-1.5%
Year over year · fewer shares
Price change (1Y)
+11.3%
Trailing year
Short interest
5.4%
Latest settlement · 4.4 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 14.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −14%
below
Price vs 50-day avg −11%
below
RSI (14) 35
neutral
MACD trend Negative
52-week position 31%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −7%
trailing
6-month return −11%
trailing
YTD return −5%
this year
Relative strength −31%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $166 › 200d $171 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +73 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.43% of float · ▲ +12.5% MoM · 4.4 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr low
681 holders — near 3-yr low, contrarian setup
Squeeze score 55
elevated · 0–100
Fundamentals
Excellent
Revenue growth +24%
Y/Y
Gross margin 700%
contracting
EPS growth +1%
Y/Y
Free cash flow $490.8M
Valuation P/E 25.7
below peers
Buyback $733.3M
remaining
Quant / Vol
risk profile
Moderate
Volatility 39%
annualized · 1-yr
Max drawdown −26%
past year
ATR 3.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 1 of last 2
Latest guidance · from the 8-K filed Jul 29, 2026
Q3'26
GAAP Gross Margin Initiated 67.5% – 68.5%
Non-GAAP Gross Margin Initiated 71%
GAAP Operating Margin Initiated 13.5% – 15%
fiscal 2026
Clear Aligner volume growth Initiated 6%
GAAP Operating Margin Initiated 15.1% – 15.6%
GAAP Gross Margin Initiated 70.2% – 70.5%
Share repurchases Initiated $400M – $500M
Capital expenditures Initiated $125M – $150M
Non-GAAP Operating Margin Initiated 23.7%
Q3 2026
Non-GAAP operating margin Initiated 24%
Fiscal 2026
Non-GAAP gross margin Initiated 71.7%
Prior guidance period ended · from the 8-K filed Jul 24, 2024
Total revenue growth · fiscal 2024 4% – 6%
Guided vs delivered · last 2 settled
Worldwide revenues Q2'24
guided $1.03B – $1.05B
$1.03B Miss −1.1%
2021 revenue 2021
guided $3.85B – $3.95B
$3.95B Beat +1.3%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−14% Bearish
Price vs 50-day avg
−11% Bearish
RSI (14)
35 Neutral
MACD trend
Negative Bearish
52-week position
31% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $166 › 200d $171 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +73 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.43% of float · ▲ +12.5% MoM · 4.4 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr low
681 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $125 Now $148 · 31% Range high $198
vs 200-day avg -14% vs 50-day avg -11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ALGN
Align Technology Inc
this stock
$10.48B -5.5% +23.9% 25.7 5.4%
ISRG
Intuitive Surgical Inc
 $137.70B -30.6% +20.5% 44.8 2.2%
BDX
Becton Dickinson & Co
 $50.64B — +8.2% — 3.9%
MDLN
Medline Inc.
 $41.60B -24.7% +11.5% — 3.0%
RMD
Resmed Inc
 $32.46B -6.6% +13.4% 21.6 9.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
681
% held
103.7%
Net QoQ
+2.5M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
627
View
Short & Settlement
Short Interest Rising
Shares short
3.9M
Days to cover
4.4d
Change
+429.7K sh
View
Short Volume
Short vol %
74%
As of
Sep 18, 2026
Short Total
View
Fails to Deliver
FTD shares
23
Value
$3.7K
As of
Aug 27, 2026
View
Off-Exchange
Off-exchange %
45.2%
Week of
Aug 17, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Sep 11, 2025
View
Financials
Financials
Revenue (FY)
$4.0B
Net income (FY)
$410.4M
EPS diluted
$5.65
View
Buybacks
Authorized
$1.0B
Remaining
$733.3M
Spent Remaining
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Sep 15, 2026
This year
15
View
Proposed Sales
Value
$1.5M
Shares
8.0K
Filed
Feb 12, 2026
View
Earnings & Events
Earnings Calls
Last call
Sep 15, 2026
View

Performance

5D 20D 120D MTD YTD
ALGN -2.1% -7.1% -11.3% -7.6% -5.5%
SPY -0.3% -0.1% +20.1% -0.7% +11.7%
vs SPY -1.8% -7.0% -31.4% -6.9% -17.2%

Capital returns

Buyback program · as of Jun 30, 2026
Authorized
$1.00B
Spent (derived)
$266.70M
Remaining
$733.30M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1097149 CUSIP 016255101 13F (30d) 18 filings 16 filers Visit website Investor relations